Publications in collaboration with researchers from Hannover Medical School (1)

2024

  1. Safety and efficacy of belantamab mafodotin with pembrolizumab in patients with relapsed or refractory multiple myeloma

    Cancer, Vol. 130, Núm. 15, pp. 2629-2641